Seambiotic, a Tel Aviv, Israel-based leader in the development and production of marine microalgae for the nutraceutical and biofuel industries, announced today that its US subsidiary, Seambiotic USA, has entered into an agreement with NASA Glenn Research Center to develop an on-going collaborative R&D program for optimization of open-pond microalgae growth processes.
Under a Space Act Agreement, NASA is partnering with Seambiotic USA to model growth processes for microalgae for use as aviation biofuel feedstock,” said Prof. Ami Ben-Amotz, Chief Scientific Adviser to Seambiotic.